Clinical Trial Update: CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating CytoGam for cytomegalovirus infection or disease in solid organ transplant recipients. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CytoGam (Cytomegalovirus immune globulin)

Snippet

Sponsor: Fernanda P Silveira, MD, MS | Conditions: Cytomegalovirus (CMV) Infection | Phase 4 | Status: ENROLLING_BY_INVITATION